BDBM128323 US8796280, 12
SMILES: CN(Cc1ccc(cc1)-c1nccnc1NS(=O)(=O)c1cccs1)c1ccc(Cl)cc1
InChI Key: InChIKey=DSGSUUPWAPBDII-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G protein-coupled receptor 44 (Homo sapiens (Human)) | BDBM128323 (US8796280, 12) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 8.43E+3 | -6.92 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Merck Serono, S.A. US Patent | Assay Description The compounds of the present invention inhibit the binding of PGD2 to its receptor CRTH2. The inhibitory activity can be investigated by a radioligan... | US Patent US8796280 (2014) BindingDB Entry DOI: 10.7270/Q2RV0MCF | |||||||||||
More data for this Ligand-Target Pair |